Iproniazid (Standard)

Overview

Iproniazid (Standard) is the analytical standard of Iproniazid ( HY-B0886A ). This product is intended for research and analytical applications. Iproniazid is an orally active, irreversible, non-selective monoamine oxidase ( MAO ) inhibitor. Iproniazid inhibits MAO activity and enhances Rotenone ( HY-B1756 )-induced Apoptosis . Iproniazid modulates neurotransmitter levels, affects neuronal function, induces hepatic necrosis, and interferes with the endocrine system. Iproniazid can be used in the research of depression, Parkinson's disease, and hepatotoxicity.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-B0886AR
• CAS No.: 54-92-2
• Molecular Formula: C9H13N3O
• Molecular Weight: 179.22
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source